组别

1月后预后良好率

3月后预后良好率

EVD-LP组

29/39 (74.4%)

32/39 (82.1%)

EVD组

7/13 (53.8%)

7/13 (53.8%)

c²值

1.926

4.1368

P值

>0.05

<0.05